Paulo Andres Torres-Lopez, MD
Hospitalist · Fredericksburg, VANPI 1467689273
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $445 and has fallen 94.2% since, to $26 in 2025. Among hospitalist clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$266
- Novo Nordisk$185
- AstraZeneca$169
- AbbVie$161
- Johnson & Johnson$136
- Lilly USA, LLC$92
- plus $477 from 12 others
What the payments were for
- Food & beverage$1,486100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 17 | $266 |
| Novo Nordisk | 10 | $185 |
| AstraZeneca(2 entities) | 13 | $169 |
| AbbVie(2 entities) | 10 | $161 |
| Johnson & Johnson | 8 | $136 |
| Lilly USA, LLC | 6 | $92 |
| Genentech USA, Inc. | 4 | $76 |
| Melinta Therapeutics, LLC | 3 | $68 |
| GSK | 5 | $67 |
| Amgen(2 entities) | 2 | $53 |
| Boehringer Ingelheim | 3 | $44 |
| Sunovion Pharmaceuticals Inc. | 2 | $41 |
| Scilex Pharmaceuticals Inc. | 2 | $30 |
| Phadia US Inc. | 1 | $27 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Pfizer | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
How this compares
$1,486 in reported general payments places this provider in the 95th percentile of 539 hospitalist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $253 |
| Metformin Hcl | 13 | $58 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Fredericksburg
- Roya QaemiFredericksburg$2K
- Zalmai AfzaliFredericksburg$2K
- Imran AhmadFredericksburg$1K
- Hammad HafeezFredericksburg$1K
- Feroz TamanaFredericksburg$1K
- Rahel DagneFredericksburg$985
- Muhammad AsifFredericksburg$941
- Hosameldin BebarsFredericksburg$927
- Barbara NewbergFredericksburg$710
- Mustafa SaidiFredericksburg$654
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.